$134.53
al cierre: Aug 27 EDT
$134.53
0.000.00%
Pre-comercialización: 6:11 PM EDT
Comments
Loading...
Insmed Actividad de operaciones con información privilegiada
INSMNASDAQ
Actividad de operaciones de insiders
Sigue la actividad de operaciones con información privilegiada más reciente de Insmed. Mantente informado sobre las compras, ventas e impacto en el mercado recientes de las acciones de Insmed.
¿Qué es la actividad interna?
La actividad de uso de información privilegiada involucra a personas con información privilegiada de la empresa, como ejecutivos, directores y empleados, que participan en transacciones con acciones de su propia empresa. Las transacciones de compra y venta de los iniciados proporcionan información valiosa sobre su confianza en el desempeño futuro de la empresa.
¿Qué están haciendo Insmed Inc los iniciados?
En Insmed Inc, la reciente actividad interna ha llamado la atención. Durante los últimos 30 días, los insiders han informado que han vendido un total de 71.10K acciones por valor de $6.97M, mientras tanto, los insiders han no reportar compras en los últimos 30 días.
Compras y ventas recientes notables de información privilegiada
- El junio 4, 2025, Michael A. Smith, la empresa CHIEF LEGAL OFFICER sold 1.45K acciones por $71.5 cada una.
- El junio 4, 2025, Sara Bonstein, la empresa CHIEF FINANCIAL OFFICER sold 1.58K acciones por $71.5 cada una.
- El junio 4, 2025, S. Nicole Schaeffer, la empresa CHIEF PEOPLE STRATEGY OFFICER sold 1.64K acciones por $71.5 cada una.
Estadísticas de propiedad de Insmed Inc
Acciones en circulación
211.375M
Acciones en manos de personas con información privilegiada
6.379M
Porcentaje de acciones en manos de personas con información privilegiada
3.36%
Acciones en manos de instituciones
140.120M
Porcentaje de acciones en manos de instituciones
66.4%
Aug 21, 2025 | DIRECTOR | -10.00K | $129.50 | -$1.29M | SELL | -3.51% | 274.62K | Aug 20 | ||
Aug 21, 2025 | CHIEF OPERATING OFFICER | -25.00K | $127.58 | -$3.19M | SELL | -19.14% | 105.64K | Aug 19 | ||
Aug 20, 2025 | CHAIR AND CEO | 0.00 | $69.63 | -$806.98K | SELL-OPTIONS | 0.00% | 284.42K | Aug 18 | ||
Aug 18, 2025 | CHIEF PEOPLE STRATEGY OFFICER | -10.00K | $127.34 | -$1.27M | SELL | -11.14% | 79.76K | Aug 14 | ||
Aug 14, 2025 | DIRECTOR | -26.10K | $121.58 | -$1.22M | SELL | -78.98% | 6.95K | Aug 12 - Aug 13 | ||
Aug 06, 2025 | CHAIR AND CEO | 0.00 | $60.33 | -$675.90K | SELL-OPTIONS | 0.00% | 284.42K | Aug 04 | ||
Aug 06, 2025 | CHIEF MEDICAL OFFICER | 0.00 | $64.62 | -$782.26K | SELL-OPTIONS | 0.00% | 83.11K | Aug 04 | ||
Jul 23, 2025 | CHIEF FINANCIAL OFFICER | -10.51K | $66.65 | -$4.53M | SELL | -12.51% | 73.50K | Jul 21 | ||
Jul 15, 2025 | CHAIR AND CEO | 0.00 | $56.61 | -$625.11K | SELL-OPTIONS | 0.00% | 284.42K | Jul 15 | ||
Jul 15, 2025 | CHIEF LEGAL OFFICER | -1.68K | $99.80 | -$167.76K | SELL | -2.47% | 66.39K | Jul 11 - Jul 15 | ||
Jul 09, 2025 | CHIEF FINANCIAL OFFICER | -9.88K | $60.64 | -$4.32M | SELL | -10.52% | 84.02K | Jul 07 | ||
Jul 02, 2025 | CHAIR AND CEO | 0.00 | $54.59 | -$597.51K | SELL-OPTIONS | 0.00% | 284.42K | Jul 01 | ||
Jun 25, 2025 | CHIEF FINANCIAL OFFICER | -9.88K | $60.47 | -$4.96M | SELL | -9.55% | 93.54K | Jun 23 | ||
Jun 18, 2025 | CHAIR AND CEO | -5.20K | $55.62 | -$12.15M | SELL | -1.80% | 284.42K | Jun 16 | ||
Jun 18, 2025 | CHIEF OPERATING OFFICER | -10.69K | $98.82 | -$1.06M | SELL | -7.56% | 130.64K | Jun 16 | ||
Jun 12, 2025 | CHIEF MEDICAL OFFICER | 0.00 | $56.79 | -$3.10M | SELL-OPTIONS | 0.00% | 83.11K | Jun 10 - Jun 11 | ||
Jun 12, 2025 | CHIEF PEOPLE STRATEGY OFFICER | -29.17K | $53.57 | -$11.03M | SELL | -24.60% | 89.41K | Jun 10 - Jun 11 | ||
Jun 12, 2025 | CHIEF FINANCIAL OFFICER | -9.88K | $53.57 | -$4.29M | SELL | -8.72% | 103.41K | Jun 10 | ||
Jun 06, 2025 | CHIEF LEGAL OFFICER | -1.88K | $73.50 | -$138.11K | SELL | -2.70% | 67.72K | Jun 05 | ||
Jun 04, 2025 | CHIEF LEGAL OFFICER | -1.45K | $71.50 | -$103.53K | SELL | -2.04% | 69.60K | Jun 03 | ||
Jun 04, 2025 | CHIEF MEDICAL OFFICER | -1.69K | $71.50 | -$120.55K | SELL | -1.99% | 83.11K | Jun 03 | ||
Jun 04, 2025 | CHIEF OPERATING OFFICER | -1.86K | $71.50 | -$132.99K | SELL | -1.30% | 141.32K | Jun 03 | ||
Jun 04, 2025 | CHIEF FINANCIAL OFFICER | -1.58K | $71.50 | -$112.90K | SELL | -1.37% | 113.29K | Jun 03 | ||
Jun 04, 2025 | CHIEF PEOPLE STRATEGY OFFICER | -1.64K | $71.50 | -$117.40K | SELL | -1.37% | 118.58K | Jun 03 | ||
Jun 04, 2025 | DIRECTOR | -6.25K | $72.25 | -$451.54K | SELL | -6.01% | 97.72K | Jun 03 - Jun 04 | ||
Jun 04, 2025 | CHAIR AND CEO | -5.47K | $41.12 | -$804.19K | SELL | -1.50% | 359.26K | Jun 02 - Jun 03 | ||
Jun 03, 2025 | CHIEF LEGAL OFFICER | -26.33K | $69.65 | -$1.83M | SELL | -27.04% | 71.05K | May 30 | ||
May 22, 2025 | DIRECTOR | 3.02K | $66.68 | $201.69K | BUY | 4.51% | 70.03K | May 20 - May 21 | ||
May 22, 2025 | CHAIR AND CEO | -21.06K | $39.26 | -$1.81M | SELL | -6.89% | 284.42K | May 20 | ||
May 19, 2025 | CHIEF MEDICAL OFFICER | -5.22K | $65.79 | -$771.28K | SELL | -5.79% | 84.80K | May 15 - May 16 | ||
May 15, 2025 | CHIEF LEGAL OFFICER | -4.82K | $67.62 | -$325.67K | SELL | -4.98% | 91.79K | May 13 - May 14 | ||
May 15, 2025 | CHIEF PEOPLE STRATEGY OFFICER | -6.24K | $67.37 | -$420.08K | SELL | -5.16% | 114.64K | May 13 - May 14 | ||
May 15, 2025 | CHAIR AND CEO | -21.21K | $66.73 | -$1.42M | SELL | -5.51% | 363.47K | May 13 - May 14 | ||
May 15, 2025 | CHIEF MEDICAL OFFICER | -10.15K | $67.43 | -$684.57K | SELL | -10.14% | 90.01K | May 13 - May 14 | ||
May 15, 2025 | CHIEF FINANCIAL OFFICER | -10.50K | $67.47 | -$708.68K | SELL | -8.84% | 108.36K | May 13 - May 14 | ||
May 15, 2025 | CHIEF OPERATING OFFICER | -9.41K | $67.36 | -$633.65K | SELL | -6.44% | 136.68K | May 13 - May 14 | ||
May 02, 2025 | CHAIR AND CEO | 0.00 | $41.71 | -$421.56K | SELL-OPTIONS | 0.00% | 284.42K | May 01 | ||
Apr 16, 2025 | CHAIR AND CEO | 0.00 | $40.50 | -$405.07K | SELL-OPTIONS | 0.00% | 284.42K | Apr 15 | ||
Apr 03, 2025 | CHAIR AND CEO | 0.00 | $42.22 | -$428.47K | SELL-OPTIONS | 0.00% | 284.42K | Apr 01 | ||
Mar 19, 2025 | CHAIR AND CEO | 0.00 | $48.30 | -$1.47M | SELL-OPTIONS | 0.00% | 284.42K | Mar 17 | ||
Mar 05, 2025 | CHAIR AND CEO | 0.00 | $48.68 | -$1.49M | SELL-OPTIONS | 0.00% | 284.42K | Mar 03 | ||
Feb 20, 2025 | CHAIR AND CEO | 0.00 | $50.30 | -$1.57M | SELL-OPTIONS | 0.00% | 284.42K | Feb 18 | ||
Feb 20, 2025 | CHIEF FINANCIAL OFFICER | -18.32K | $80.31 | -$1.47M | SELL | -13.36% | 118.86K | Feb 18 | ||
Feb 13, 2025 | CHIEF FINANCIAL OFFICER | -18.32K | $80.00 | -$1.47M | SELL | -11.78% | 137.19K | Feb 11 - Feb 12 | ||
Feb 12, 2025 | CHIEF OPERATING OFFICER | -42.98K | $78.61 | -$3.38M | SELL | -22.73% | 146.08K | Feb 10 | ||
Feb 12, 2025 | CHIEF MEDICAL OFFICER | -37.83K | $78.61 | -$2.97M | SELL | -27.41% | 100.17K | Feb 10 | ||
Feb 07, 2025 | CHIEF MEDICAL OFFICER | 37.83K | $80.90 | -$2.68M | GRANT | 37.77% | 137.99K | Feb 05 - Feb 07 | ||
Feb 07, 2025 | CHIEF PEOPLE STRATEGY OFFICER | 23.80K | $80.90 | -$1.90M | GRANT | 24.51% | 120.88K | Feb 05 - Feb 06 | ||
Feb 07, 2025 | CHIEF OPERATING OFFICER | 42.98K | $80.90 | -$3.70M | GRANT | 29.42% | 189.06K | Feb 05 - Feb 07 | ||
Feb 07, 2025 | CHAIR AND CEO | 74.36K | $80.90 | -$6.42M | GRANT | 17.29% | 504.39K | Feb 05 - Feb 06 | ||
Feb 07, 2025 | CHIEF COMMERCIAL OFFICER | 7.45K | $80.90 | -$640.71K | GRANT | 5.94% | 133.01K | Feb 05 - Feb 07 | ||
Feb 07, 2025 | CHIEF FINANCIAL OFFICER | 36.64K | $80.90 | -$2.30M | GRANT | 30.83% | 155.51K | Feb 05 - Feb 06 | ||
Feb 07, 2025 | CHIEF LEGAL OFFICER | 26.64K | $80.90 | -$1.67M | GRANT | 38.08% | 96.61K | Feb 05 - Feb 06 | ||
Feb 05, 2025 | CHAIR AND CEO | 0.00 | $48.76 | -$1.49M | SELL-OPTIONS | 0.00% | 284.42K | Feb 03 | ||
Jan 31, 2025 | CHIEF PEOPLE STRATEGY OFFICER | 0.00 | $47.52 | -$5.92M | SELL-OPTIONS | 0.00% | 97.08K | Jan 30 | ||
Jan 16, 2025 | CHIEF MEDICAL OFFICER | -1.38K | $68.72 | -$95.11K | SELL | -1.36% | 100.17K | Jan 14 | ||
Jan 16, 2025 | CHIEF OPERATING OFFICER | -1.46K | $68.72 | -$100.13K | SELL | -0.99% | 146.08K | Jan 14 | ||
Jan 16, 2025 | CHIEF PEOPLE STRATEGY OFFICER | -872.00 | $68.72 | -$59.92K | SELL | -0.89% | 97.08K | Jan 14 | ||
Jan 16, 2025 | CHAIR AND CEO | -13.05K | $44.88 | -$2.21M | SELL | -4.39% | 284.42K | Jan 15 | ||
Jan 10, 2025 | CHIEF MEDICAL OFFICER | -4.56K | $64.70 | -$725.82K | SELL | -4.30% | 101.55K | Jan 07 - Jan 10 | ||
Jan 10, 2025 | CHIEF FINANCIAL OFFICER | 657.00 | $65.43 | -$392.60K | GRANT | 0.56% | 118.86K | Jan 07 - Jan 10 | ||
Jan 10, 2025 | CHIEF PEOPLE STRATEGY OFFICER | -2.16K | $64.74 | -$508.97K | SELL | -2.15% | 97.95K | Jan 07 - Jan 10 | ||
Jan 10, 2025 | CHIEF COMMERCIAL OFFICER | 3.07K | $41.01 | -$735.37K | SELL-OPTIONS | 2.51% | 125.56K | Jan 07 - Jan 10 | ||
Jan 10, 2025 | CHAIR AND CEO | 7.63K | $65.48 | -$995.01K | GRANT | 1.75% | 443.09K | Jan 07 - Jan 10 | ||
Jan 10, 2025 | CHIEF LEGAL OFFICER | 2.02K | $65.82 | -$242.82K | GRANT | 2.97% | 69.97K | Jan 07 - Jan 10 | ||
Jan 10, 2025 | CHIEF OPERATING OFFICER | -2.57K | $64.78 | -$597.76K | SELL | -1.71% | 147.54K | Jan 07 - Jan 10 | ||
Jan 03, 2025 | CHAIR AND CEO | 0.00 | $44.71 | -$1.29M | SELL-OPTIONS | 0.00% | 284.42K | Jan 02 | ||
Dec 20, 2024 | CHAIR AND CEO | 0.00 | $44.75 | -$1.29M | SELL-OPTIONS | 0.00% | 284.42K | Dec 19 | ||
Dec 13, 2024 | CHAIR AND CEO | 0.00 | $46.28 | -$1.37M | SELL-OPTIONS | 0.00% | 284.42K | Dec 12 | ||
Sep 16, 2024 | CHIEF LEGAL OFFICER | -20.87K | $48.56 | -$1.91M | SELL | -23.52% | 67.86K | Sep 13 | ||
Sep 16, 2024 | CHIEF MEDICAL OFFICER | 0.00 | $54.47 | -$1.68M | SELL-OPTIONS | 0.00% | 106.13K | Sep 12 - Sep 16 | ||
Sep 10, 2024 | CHIEF PEOPLE STRATEGY OFFICER | 0.00 | $41.18 | -$2.28M | SELL-OPTIONS | 0.00% | 100.10K | Sep 10 | ||
Sep 10, 2024 | CHIEF MEDICAL OFFICER | 0.00 | $47.00 | -$7.22M | SELL-OPTIONS | 0.00% | 106.13K | Sep 06 | ||
Aug 14, 2024 | CHIEF LEGAL OFFICER | 0.00 | $44.27 | -$5.05M | SELL-OPTIONS | 0.00% | 88.73K | Aug 12 | ||
Aug 14, 2024 | CHIEF PEOPLE STRATEGY OFFICER | -9.47K | $72.49 | -$686.41K | SELL | -8.64% | 100.10K | Aug 12 | ||
Jun 12, 2024 | CHIEF MEDICAL OFFICER | 0.00 | $41.88 | -$768.32K | SELL-OPTIONS | 0.00% | 106.13K | Jun 10 | ||
Jun 05, 2024 | CHIEF PEOPLE STRATEGY OFFICER | 0.00 | $38.21 | -$1.88M | SELL-OPTIONS | 0.00% | 108.76K | Jun 03 | ||
May 30, 2024 | CHIEF COMMERCIAL OFFICER | -1.60K | $31.18 | -$312.29K | SELL | -1.30% | 121.66K | May 28 | ||
May 30, 2024 | CHIEF LEGAL OFFICER | -5.75K | $31.90 | -$1.66M | SELL | -6.08% | 88.83K | May 28 | ||
May 30, 2024 | CHIEF PEOPLE STRATEGY OFFICER | 0.00 | $31.05 | -$1.02M | SELL-OPTIONS | 0.00% | 108.76K | May 28 | ||
May 30, 2024 | CHIEF MEDICAL OFFICER | 0.00 | $37.10 | -$3.36M | SELL-OPTIONS | 0.00% | 106.13K | May 28 - May 30 | ||
May 30, 2024 | CHIEF FINANCIAL OFFICER | 0.00 | $38.27 | -$5.66M | SELL-OPTIONS | 0.00% | 117.48K | May 28 - May 29 | ||
May 17, 2024 | CHIEF MEDICAL OFFICER | -4.64K | $25.09 | -$116.47K | SELL | -4.19% | 106.13K | May 17 | ||
May 17, 2024 | CHIEF OPERATING OFFICER | -5.95K | $25.09 | -$149.16K | SELL | -3.83% | 149.28K | May 17 | ||
May 15, 2024 | CHIEF COMMERCIAL OFFICER | 9.43K | $25.47 | -$129.59K | GRANT | 8.28% | 123.26K | May 13 - May 14 | ||
May 15, 2024 | CHIEF LEGAL OFFICER | 8.21K | $25.40 | -$129.36K | GRANT | 9.51% | 94.58K | May 13 - May 14 | ||
May 15, 2024 | CHIEF PEOPLE STRATEGY OFFICER | 6.80K | $25.53 | -$166.15K | GRANT | 6.67% | 108.76K | May 13 - May 14 | ||
May 15, 2024 | CHAIR AND CEO | 20.51K | $25.52 | -$566.49K | GRANT | 4.95% | 434.63K | May 13 - May 14 | ||
May 15, 2024 | CHIEF MEDICAL OFFICER | 3.88K | $25.47 | -$271.00K | GRANT | 3.63% | 110.78K | May 13 - May 14 | ||
May 15, 2024 | CHIEF FINANCIAL OFFICER | 3.43K | $25.32 | -$280.75K | GRANT | 3.01% | 117.48K | May 13 - May 14 | ||
May 15, 2024 | CHIEF OPERATING OFFICER | 6.66K | $25.50 | -$200.35K | GRANT | 4.48% | 155.22K | May 13 - May 14 | ||
Jan 12, 2024 | CHIEF MEDICAL OFFICER | -4.67K | $28.63 | -$133.62K | SELL | -4.18% | 106.90K | Jan 12 | ||
Jan 12, 2024 | CHIEF OPERATING OFFICER | -5.25K | $28.63 | -$150.34K | SELL | -3.41% | 148.56K | Jan 12 | ||
Jan 11, 2024 | CHIEF COMMERCIAL OFFICER | -1.86K | $28.78 | -$53.56K | SELL | -1.61% | 113.83K | Jan 09 | ||
Jan 11, 2024 | GENERAL COUNSEL, SENIOR VP | -2.37K | $28.76 | -$68.25K | SELL | -2.67% | 86.36K | Jan 09 | ||
Jan 11, 2024 | CHIEF PEOPLE STRATEGY OFFICER | -3.17K | $24.67 | -$95.52K | SELL | -3.01% | 101.98K | Jan 09 | ||
Jan 11, 2024 | CHIEF MEDICAL OFFICER | -5.96K | $28.99 | -$172.76K | SELL | -5.07% | 111.56K | Jan 09 - Jan 10 | ||
Jan 11, 2024 | CHIEF FINANCIAL OFFICER | -4.50K | $29.18 | -$131.22K | SELL | -3.79% | 114.05K | Jan 09 | ||
Jan 11, 2024 | CHIEF OPERATING OFFICER | -7.37K | $29.08 | -$214.42K | SELL | -4.57% | 153.81K | Jan 09 - Jan 10 | ||
Jan 10, 2024 | CHAIR AND CEO | -9.89K | $24.91 | -$688.42K | SELL | -2.64% | 364.15K | Jan 08 - Jan 09 | ||
Jan 05, 2024 | CHIEF COMMERCIAL OFFICER | 11.71K | $24.15 | -$236.53K | SELL-OPTIONS | 11.26% | 115.69K | Jan 03 - Jan 05 | ||
Jan 05, 2024 | GENERAL COUNSEL, SENIOR VP | 11.17K | $29.30 | -$18.37K | GRANT | 14.40% | 88.74K | Jan 04 - Jan 05 | ||
Jan 05, 2024 | CHIEF PEOPLE STRATEGY OFFICER | 10.34K | $29.28 | -$42.66K | GRANT | 10.91% | 105.15K | Jan 04 - Jan 05 | ||
Jan 05, 2024 | CHAIR AND CEO | 30.89K | $29.26 | -$204.20K | GRANT | 9.00% | 374.04K | Jan 04 - Jan 05 | ||
Jan 05, 2024 | CHIEF MEDICAL OFFICER | 11.49K | $29.20 | -$40.48K | GRANT | 10.83% | 117.53K | Jan 04 - Jan 05 | ||
Jan 05, 2024 | CHIEF OPERATING OFFICER | 9.83K | $29.21 | -$88.86K | GRANT | 6.50% | 161.18K | Jan 04 - Jan 05 | ||
Jan 02, 2024 | CHIEF PEOPLE STRATEGY OFFICER | 0.00 | $26.24 | -$256.53K | SELL-OPTIONS | 0.00% | 94.55K | Dec 28 | ||
Dec 22, 2023 | CHIEF MEDICAL OFFICER | 0.00 | $26.83 | -$179.49K | SELL-OPTIONS | 0.00% | 106.04K | Dec 22 | ||
Dec 22, 2023 | CHIEF FINANCIAL OFFICER | -13.20K | $30.00 | -$395.97K | SELL | -11.14% | 105.24K | Dec 22 | ||
Oct 31, 2023 | CHAIR AND CEO | 500.00 | $19.16 | -$1.09M | SELL-OPTIONS | 0.09% | 576.57K | Oct 27 | ||
Jul 13, 2023 | GENERAL COUNSEL, SENIOR VP | -740.00 | $20.18 | -$14.93K | SELL | -0.95% | 77.14K | Jul 11 | ||
Jun 15, 2023 | CHIEF MEDICAL OFFICER | -8.87K | $19.27 | -$170.89K | SELL | -7.72% | 106.04K | Jun 13 | ||
Jun 15, 2023 | CHIEF OPERATING OFFICER | -8.98K | $19.32 | -$173.51K | SELL | -5.60% | 151.35K | Jun 13 | ||
May 26, 2023 | CHIEF COMMERCIAL OFFICER | -3.37K | $18.95 | -$63.79K | SELL | -3.17% | 102.68K | May 25 | ||
May 17, 2023 | CHIEF COMMERCIAL OFFICER | -2.89K | $18.44 | -$53.22K | SELL | -2.65% | 106.05K | May 15 - May 17 | ||
May 17, 2023 | GENERAL COUNSEL, SENIOR VP | -3.63K | $18.77 | -$68.21K | SELL | -4.50% | 77.08K | May 15 - May 17 | ||
May 17, 2023 | CHIEF PEOPLE STRATEGY OFFICER | -5.02K | $18.62 | -$93.44K | SELL | -5.09% | 93.53K | May 15 - May 17 | ||
May 17, 2023 | CHAIR AND CEO | -16.86K | $18.58 | -$313.31K | SELL | -2.85% | 575.27K | May 15 - May 17 | ||
May 17, 2023 | CHIEF MEDICAL OFFICER | -4.29K | $18.94 | -$81.33K | SELL | -3.60% | 114.91K | May 15 - May 16 | ||
May 17, 2023 | CHIEF FINANCIAL OFFICER | -3.82K | $18.95 | -$72.39K | SELL | -3.15% | 117.62K | May 15 - May 16 | ||
May 17, 2023 | CHIEF OPERATING OFFICER | -6.82K | $18.66 | -$127.19K | SELL | -4.08% | 160.33K | May 15 - May 17 | ||
May 17, 2023 | DIRECTOR | 20.00K | $19.29 | $385.80K | BUY | ∞ | 11.85K | May 15 | ||
Jan 12, 2023 | CHIEF COMMERCIAL OFFICER | -779.00 | $17.96 | -$13.99K | SELL | -1.00% | 77.27K | Jan 10 | ||
Jan 12, 2023 | GENERAL COUNSEL, SENIOR VP | -1.84K | $17.93 | -$32.92K | SELL | -3.27% | 54.33K | Jan 10 | ||
Jan 12, 2023 | CHIEF PEOPLE STRATEGY OFFICER | -2.44K | $17.95 | -$43.71K | SELL | -3.26% | 72.16K | Jan 10 | ||
Jan 12, 2023 | CHAIR AND CEO | -6.99K | $18.00 | -$125.89K | SELL | -2.57% | 265.07K | Jan 10 | ||
Jan 12, 2023 | CHIEF MEDICAL OFFICER | -3.44K | $18.06 | -$62.11K | SELL | -4.51% | 72.76K | Jan 10 | ||
Jan 12, 2023 | CHIEF FINANCIAL OFFICER | -2.86K | $18.12 | -$51.77K | SELL | -4.15% | 66.03K | Jan 10 | ||
Jan 12, 2023 | CHIEF OPERATING OFFICER | -3.19K | $17.99 | -$57.46K | SELL | -2.30% | 135.49K | Jan 10 | ||
Jan 06, 2023 | CHIEF COMMERCIAL OFFICER | 6.44K | $19.74 | -$22.90K | GRANT | 8.99% | 78.05K | Jan 05 | ||
Jan 06, 2023 | GENERAL COUNSEL, SENIOR VP | 5.61K | $19.72 | -$14.20K | GRANT | 11.10% | 56.17K | Jan 05 | ||
Jan 06, 2023 | CHIEF PEOPLE STRATEGY OFFICER | 4.88K | $19.73 | -$28.57K | GRANT | 7.01% | 74.59K | Jan 05 | ||
Jan 06, 2023 | CHAIR AND CEO | 15.35K | $19.80 | -$138.76K | GRANT | 5.98% | 272.06K | Jan 05 | ||
Jan 06, 2023 | CHIEF MEDICAL OFFICER | 9.77K | $19.73 | -$27.11K | GRANT | 14.71% | 76.20K | Jan 05 | ||
Jan 06, 2023 | CHIEF OPERATING OFFICER | 4.55K | $19.75 | -$60.12K | GRANT | 3.40% | 138.68K | Jan 05 | ||
Nov 22, 2022 | CHIEF COMMERCIAL OFFICER | -7.15K | $18.84 | -$134.78K | SELL | -9.08% | 71.61K | Nov 22 | ||
Nov 22, 2022 | CHIEF OPERATING OFFICER | -11.86K | $18.80 | -$222.87K | SELL | -8.12% | 134.13K | Nov 22 | ||
Nov 02, 2022 | DIRECTOR | 30.00K | $17.59 | $527.60K | BUY | ∞ | 17.50K | Oct 31 - Nov 01 | ||
Nov 02, 2022 | DIRECTOR | 45.00K | $17.69 | $796.05K | BUY | 84.48% | 98.27K | Oct 31 | ||
Aug 12, 2022 | CHIEF COMMERCIAL OFFICER | -258.00 | $27.79 | -$7.17K | SELL | -0.33% | 78.77K | Aug 10 | ||
Aug 10, 2022 | CHAIR AND CEO | 0.00 | $16.11 | -$5.08M | SELL-OPTIONS | 0.00% | 256.72K | Aug 08 | ||
Jul 12, 2022 | GENERAL COUNSEL, SENIOR VP | -941.00 | $23.40 | -$22.02K | SELL | -1.83% | 50.45K | Jul 12 | ||
Jul 08, 2022 | CHAIR AND CEO | 0.00 | $19.58 | -$660.84K | SELL-OPTIONS | 0.00% | 256.72K | Jul 07 | ||
May 18, 2022 | CHIEF OPERATING OFFICER | -3.42K | $19.57 | -$66.85K | SELL | -2.29% | 145.98K | May 16 - May 17 | ||
May 18, 2022 | CHIEF FINANCIAL OFFICER | -1.43K | $18.51 | -$26.52K | SELL | -2.55% | 54.68K | May 16 | ||
May 18, 2022 | CHIEF MEDICAL OFFICER | -1.57K | $18.51 | -$29.13K | SELL | -2.31% | 66.43K | May 16 | ||
May 18, 2022 | CHIEF PEOPLE STRATEGY OFFICER | -2.78K | $19.53 | -$54.36K | SELL | -3.89% | 68.82K | May 16 - May 17 | ||
May 18, 2022 | GENERAL COUNSEL, SENIOR VP | -1.49K | $19.82 | -$29.49K | SELL | -2.86% | 50.58K | May 16 - May 17 | ||
May 18, 2022 | CHAIR AND CEO | -9.39K | $19.52 | -$183.35K | SELL | -3.54% | 255.83K | May 16 - May 17 | ||
May 13, 2022 | — | 34.65K | $17.20 | $344.00K | BUY | 15.12% | 263.81K | May 11 | ||
Mar 25, 2022 | CHAIR AND CEO | 0.00 | $19.36 | -$734.78K | SELL-OPTIONS | 0.00% | 217.62K | Mar 23 | ||
Jan 13, 2022 | CHAIR AND CEO | -2.87K | $25.11 | -$72.14K | SELL | -1.30% | 217.62K | Jan 11 | ||
Jan 13, 2022 | GENERAL COUNSEL, SENIOR VP | -407.00 | $25.11 | -$10.22K | SELL | -1.08% | 37.43K | Jan 11 | ||
Jan 13, 2022 | CHIEF PEOPLE STRATEGY OFFICER | -925.00 | $25.11 | -$23.23K | SELL | -1.60% | 56.96K | Jan 11 | ||
Jan 13, 2022 | CHIEF OPERATING OFFICER | -1.22K | $24.58 | -$29.91K | SELL | -0.99% | 121.94K | Jan 12 | ||
Jan 13, 2022 | CHIEF MEDICAL OFFICER | -1.50K | $25.11 | -$37.54K | SELL | -3.15% | 46.04K | Jan 11 | ||
Jan 13, 2022 | CHIEF FINANCIAL OFFICER | -1.15K | $25.11 | -$28.98K | SELL | -3.11% | 35.98K | Jan 11 | ||
Jan 07, 2022 | CHIEF OPERATING OFFICER | -4.83K | $27.02 | -$130.44K | SELL | -4.38% | 105.42K | Jan 05 - Jan 06 | ||
Jan 07, 2022 | CHAIR AND CEO | -12.46K | $26.92 | -$335.51K | SELL | -6.16% | 189.76K | Jan 05 - Jan 06 | ||
Jan 07, 2022 | CHIEF MEDICAL OFFICER | -1.42K | $27.61 | -$39.29K | SELL | -4.09% | 33.34K | Jan 05 | ||
Jan 07, 2022 | CHIEF PEOPLE STRATEGY OFFICER | -3.12K | $26.78 | -$83.41K | SELL | -6.04% | 48.43K | Jan 05 - Jan 06 | ||
Jan 07, 2022 | GENERAL COUNSEL, SENIOR VP | -1.14K | $27.06 | -$30.74K | SELL | -3.85% | 28.38K | Jan 05 - Jan 06 | ||
Dec 28, 2021 | CHAIR AND CEO | 0.00 | $20.92 | -$1.36M | SELL-OPTIONS | 0.00% | 202.22K | Dec 23 - Dec 27 | ||
Nov 03, 2021 | CHIEF PEOPLE STRATEGY OFFICER | 0.00 | $21.36 | -$1.09M | SELL-OPTIONS | 0.00% | 51.51K | Nov 01 | ||
Nov 03, 2021 | — | 10.00K | $30.15 | $301.50K | BUY | 14.11% | 80.88K | Nov 01 | ||
Nov 03, 2021 | — | 14.23K | $30.14 | $429.04K | BUY | 4.64% | 320.80K | Nov 01 | ||
Oct 01, 2021 | CHAIR AND CEO | 0.00 | $15.38 | -$2.32M | SELL-OPTIONS | 0.00% | 202.22K | Sep 30 | ||
Sep 09, 2021 | CHIEF COMPLIANCE OFFICER | 0.00 | $21.05 | -$247.92K | SELL-OPTIONS | 0.00% | 35.20K | Sep 07 | ||
Mar 18, 2021 | CHAIR AND CEO | 0.00 | $19.79 | -$1.64M | SELL-OPTIONS | 0.00% | 179.61K | Mar 16 | ||
Mar 12, 2021 | CHIEF COMPLIANCE OFFICER | 0.00 | $35.43 | -$216.77K | SELL-OPTIONS | 0.00% | 29.77K | Mar 11 | ||
Mar 11, 2021 | CHIEF COMPLIANCE OFFICER | 0.00 | $31.27 | -$826.66K | SELL-OPTIONS | 0.00% | 29.77K | Mar 09 - Mar 10 | ||
Mar 08, 2021 | — | 2.71K | $36.90 | $100.00K | BUY | 0.91% | 299.01K | Mar 04 | ||
Feb 10, 2021 | CHIEF LEGAL OFFICER | 0.00 | $27.77 | -$729.21K | SELL-OPTIONS | 0.00% | 140.72K | Feb 08 - Feb 09 | ||
Jan 27, 2021 | CHIEF LEGAL OFFICER | 0.00 | $27.07 | -$765.73K | SELL-OPTIONS | 0.00% | 140.72K | Jan 25 - Jan 26 | ||
Jan 22, 2021 | CHIEF LEGAL OFFICER | 0.00 | $25.91 | -$903.50K | SELL-OPTIONS | 0.00% | 140.72K | Jan 20 - Jan 21 | ||
Dec 23, 2020 | CHAIR&CHIEF EXECUTIVE OFFICER | 0.00 | $19.99 | -$1.66M | SELL-OPTIONS | 0.00% | 164.79K | Dec 22 | ||
Dec 09, 2020 | — | -20.00K | $39.57 | -$791.40K | SELL | -48.85% | 20.94K | Dec 07 | ||
Nov 24, 2020 | — | -8.00K | $39.05 | -$312.36K | SELL | -3.22% | 240.60K | Nov 20 - Nov 23 | ||
Nov 20, 2020 | — | -4.00K | $39.48 | -$157.92K | SELL | -18.51% | 17.61K | Nov 19 | ||
Nov 06, 2020 | — | 28.64K | $19.39 | -$5.79M | TAX | 21.04% | 164.79K | May 15 - Nov 06 | ||
Nov 05, 2020 | — | 38.08K | $22.19 | -$2.65M | TAX | 39.70% | 134.00K | May 15 - Nov 05 | ||
Sep 16, 2020 | — | -20.00K | $30.68 | -$613.57K | SELL | -7.45% | 248.60K | Sep 14 - Sep 15 |
PREGUNTAS FRECUENTES
¿Es legal el uso de información privilegiada?
Las operaciones con información privilegiada son legales siempre que se notifiquen a la Comisión de Bolsa y Valores (SEC). El comercio ilegal de valores se produce cuando la persona con información privilegiada viola un deber fiduciario o no informa de sus operaciones.
¿Cuáles son algunos ejemplos de manipulación del mercado?
Las operaciones con información privilegiada, los esquemas de pump and dump, el front running y las operaciones de lavado son ejemplos de manipulación del mercado. Los inversores que siguen el movimiento de activos con información privilegiada deben pensar atentamente por qué estos operadores con información privilegiada están negociando sus acciones antes de seguir adelante.
Explora operaciones con información privilegiada sobre todos los valores.